Literature DB >> 16758415

Epidemiology of community-onset candidemia in Connecticut and Maryland.

Andre N Sofair1, G Marshall Lyon, Sharon Huie-White, Errol Reiss, Lee H Harrison, Laurie Thomson Sanza, Beth A Arthington-Skaggs, Scott K Fridkin.   

Abstract

BACKGROUND: Almost one-third of patients with bloodstream infections with Candida species (candidemia) have onset of disease that occurs outside of the hospital or < or = 2 days after hospital admission (i.e., community-onset candidemia). We compared the characteristics of patients who developed candidemia by the timing of onset of infection.
METHODS: Incident episodes of candidemia were identified through active, population-based surveillance in Connecticut and in Baltimore and Baltimore County, Maryland, during 1 October 1998-30 September 2000. The molecular subtypes of a sample of 45 Candida parapsilosis isolates were evaluated using Southern blots hybridized with the complex probe Cp3-13.
RESULTS: Overall, 356 (31%) of the 1143 incident episodes of candidemia were classified as community-onset disease (occurring < or = 2 days after hospital admission), and 132 (37%) were caused by Candida albicans, 89 (25%) were caused by Candida glabrata, 57 (16%) were caused by C. parapsilosis, and 53 (15%) were caused by Candida tropicalis. Community-onset disease was less likely to be associated with concurrent immunosuppressive therapy, recent surgery, or use of a central venous catheter, compared with inpatient disease. Among patients with community-onset disease, the median time from blood culture to initiation of antifungal treatment was 2.7 days, the 30-day case-fatality rate was 26%, and 262 patients (75%) had been hospitalized at least once in the previous 3 months. Although there were few differences between patients with very recent hospitalization (in the previous 1 month), less recent hospitalization (previous 1-3 months), and no documented past hospitalization, C. parapsilosis was more frequently associated with community-onset disease as hospitalization became more distant. C. parapsilosis strains tended to be unique to the patient, with little similarity found between strain types, on the basis of epidemiologic classification of patients.
CONCLUSION: We report that community-onset candidemia is common and occurs in patients with extensive contact with the health care system. Disease caused by C. parapsilosis tends to involve unique strains.

Entities:  

Mesh:

Year:  2006        PMID: 16758415     DOI: 10.1086/504807

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  13 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

Review 2.  Comparative genomics and the evolution of pathogenicity in human pathogenic fungi.

Authors:  Gary P Moran; David C Coleman; Derek J Sullivan
Journal:  Eukaryot Cell       Date:  2010-11-12

Review 3.  Population-based epidemiology and microbiology of community-onset bloodstream infections.

Authors:  Kevin B Laupland; Deirdre L Church
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.

Authors:  Michael A Pfaller; Gary J Moet; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

5.  Burden of community-onset bloodstream infection: a population-based assessment.

Authors:  K B Laupland; D B Gregson; W W Flemons; D Hawkins; T Ross; D L Church
Journal:  Epidemiol Infect       Date:  2006-12-07       Impact factor: 2.451

6.  In vitro susceptibilities of yeast species to fluconazole and voriconazole as determined by the 2010 National China Hospital Invasive Fungal Surveillance Net (CHIF-NET) study.

Authors:  He Wang; Meng Xiao; Sharon C-A Chen; Fanrong Kong; Zi-Yong Sun; Kang Liao; Juan Lu; Hai-Feng Shao; Yan Yan; Hong Fan; Zhi-Dong Hu; Yun-Zhuo Chu; Tie-Shi Hu; Yu-Xing Ni; Gui-Ling Zou; Ying-Chun Xu
Journal:  J Clin Microbiol       Date:  2012-10-03       Impact factor: 5.948

Review 7.  Candida parapsilosis, an emerging fungal pathogen.

Authors:  David Trofa; Attila Gácser; Joshua D Nosanchuk
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Historical trends in the epidemiology of candidaemia: analysis of an 11-year period in a tertiary care hospital in Brazil.

Authors:  Marcos Paulo Wille; Thaís Guimarães; Guilherme Henrique Campos Furtado; Arnaldo Lopes Colombo
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

9.  Candida bloodstream infections in hemodialysis recipients.

Authors:  Vasilios Pyrgos; Kathryn Ratanavanich; Nancy Donegan; Judith Veis; Thomas J Walsh; Shmuel Shoham
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

10.  Mortality in patients with early- or late-onset candidaemia.

Authors:  Francesco Giuseppe De Rosa; Enrico Maria Trecarichi; Chiara Montrucchio; Angela Raffaella Losito; Stefania Raviolo; Brunella Posteraro; Silvia Corcione; Simona Di Giambenedetto; Lucina Fossati; Maurizio Sanguinetti; Roberto Serra; Roberto Cauda; Giovanni Di Perri; Mario Tumbarello
Journal:  J Antimicrob Chemother       Date:  2012-12-12       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.